The report “Business Model Analysis in Antimicrobial Coatings for Medical Devices Key Players (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE)”, report analyzes and studies the business model of market players in terms of key partners, key activities, key resources, value propositions, channels, customer segments, customer relationships, revenue streams, and competitive strategy.
Browse 9 market data Tables and 12 Figures spread through 53 Pages and in-depth TOC on "Business Model Analysis in Antimicrobial Coatings for Medical Devices"
Early buyers will receive 10% customization on this report.
Business Model – A blueprint that ensures success of businesses, aligns operations with business strategies, improves process communication, increases control and consistency, improves operational efficiencies, offers competitive advantages, and amplifies revenues
The high rate of healthcare-associated infections (HAIs) is a major challenge for hospitals and healthcare providers across the globe. Medical devices can be a major source of HAIs and the use of antimicrobial coatings on a wide range of medical devices is an important measure to curb the growing rate of HAIs.
Talk to Our Research Analysts for More Info@
Globally, a number of factors such as the increasing risk of HAIs, rising geriatric population, technological advancements, and availability of funding form various government bodies is expected to trigger the growth of the antimicrobial coatings market for medical devices. However, limitations of silver-ion coatings, presence of time- and resource-intensive processes for the development and approval of antimicrobial coatings, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market.
The antimicrobial coatings market for medical devices is marked by the presence of well-established firms as well as smaller firms. Some of the prominent players in the global antimicrobial coatings market include BASF SE (Germany), AST Products, Inc. (U.S.), BioInteractions LTD (U.K.), Covalon Technologies LTD (Canada), Sciessent LLC (U.S.), Royal DSM (Netherlands), Specialty Coating Systems, Inc. (U.S.), The Dow Chemical Company (U.S.), Hydromer, Inc. (U.S.), and PPG Industries, Inc. (U.S.).
This report provides in-depth assessment of the business models of leading companies (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE) operating in the antimicrobial coatings market for medical devices. Manufacturers, start-up firms/entrepreneurs, resellers/channel partners/distributors (citing backward integration), market research & business consulting firms, and venture capitalists/investment firms are some of the key stakeholders who are likely to benefit from the business models of market players.
Get The Sample Copy Of This Report:
The research findings cited in this report encapsulate activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributor/supplier/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue streams, among other factors are some of the key attributes that are discussed at length in this report.
Browse Related Reports:
Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020.
Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets